Sign in
4

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0001104659-21-130026

10% owner bought 187,500 shares at $16.00 ($3,000,000)

  • 10% owner acquired 2,545,529 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Atlas Venture Fund XI, L.P. · 10% owner

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-26 Conversion : show line 1 in the form +1,372,998 1,399,313 I
2021-10-26 Conversion : show line 2 in the form +624,089 2,023,402 I
2021-10-26 Conversion : show line 3 in the form +548,442 548,442 I
2021-10-26 Purchase : show line 4 in the form +187,500 $16.00 $3,000,000 735,942 I
Open-market purchases · 187,500 sh · avg $16.00 · $3,000,000

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-10-26 Conversion : show line 5 in the form Series A1 Preferred Stock −13,043,477 0 I
2021-10-26 Conversion : show line 6 in the form Series B Preferred Stock −5,928,852 0 I
2021-10-26 Conversion : show line 7 in the form Series C Preferred Stock −5,210,204 0 I
Loading xslF345X03/tm2130646-24_4seq1.xml…